This page shows the latest Fycompa news and features for those working in and with pharma, biotech and healthcare.
Eisai did likewise for its epilepsy treatment Fycompa (perampanel).
The new unit will market the company's epilepsy drug Fycompa (perampanel), which it has been giving a rolling launch across the region. ... Fycompa indicated for the adjunctive treatment of partial onset seizures, with or without secondarily generalised
Eisai opens first office in Australia. New Melbourne base to support marketing of Halaven and Fycompa. ... Fycompa is the first in a new class of treatment for partial onset seizures, the most common form of epilepsy.
Eisai "speechless" as G-BA denies price premium for Fycompa. But company has better news on cancer drug Halaven. ... Eisai's efforts to secure favourable pricing for its epilepsy drug Fycompa in Germany have hit the buffers once again.
Epilepsy is a relative new area of focus for Eisai, whose treatment options include Fycompa (perampanel), which was launched in Europe in 2012.
Eisai has issued a damning statement criticising Germany's healthcare watchdog IQWIG for not backing epilepsy drug Fycompa. ... IQWIG's recommendation will now be considered by the G-BA, which is expected to published a decision on Fycompa's use in
More from news
Approximately 13 fully matching, plus 11 partially matching documents found.
by adding a new solid dose global manufacturing line for its anti-epileptic medicine Fycompa. ... Fycompa was the first Eisai-developed epilepsy drug and it's “ a drug we can really differentiate”, says Hendler.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Virgo Health is an award-winning global healthcare communications and medical education agency comprising specialists with some of the best skills,...